23 signals · alpha_vantage, bluesky, News / RSS
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Signal data from 1 source places Relay Therapeutics in the AI Drug Discovery / Biotech space at moderate workforce stress signals with low overall risk indicators.
Signals for Relay Therapeutics were collected from 1 source. Aggregate signal sentiment appears broadly positive. The stress score stands at 35/100 with a risk score of 3/100. Signal coverage is sufficient to support a preliminary assessment.
What this means
Relay Therapeutics $RLAY Citizens Raises price target from 21.00 to 26.00. Maintains Market Outperform. https://fundspec.ai Don't just watch RLAY move, predict it! Build your own custom AI trading models for RLAY today by downloading the FundSpec App on the AppStore or PlayStore!
Maintains Market Outperform.
$RLAY: Relay Therapeutics initiated with a Buy at Canaccord stockoscope.com/stock/rlay/news#price-targets
AI-driven structure-based drug discovery.
Based on 23 signals across 3 sources · snapshot 13 Sept 2026
Strong — enough signals from diverse sources to trust this score.
Overall community sentiment for Relay Therapeutics is positive based on public signals as of 13 Sept 2026.
Based on 23 signals across 3 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Signals suggest a mixed picture — review the evidence below for context.
AI-generated from public signals — may be incomplete. Based on 3 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Relay Therapeutics $RLAY Guggenheim Raises price target from 22.00 to 26.00. Maintains Buy. https://fundspec.io Don't just watch RLAY move, predict it! Build your own custom AI trading models for RLAY today by downloading the FundSpec App on the AppStore or PlayStore!
Relay Therapeutics $RLAY Guggenheim Raises price target from 22.00 to 26.00.